telehealth glp 1 prescription Secret shopper study reveals questionable GLP-1 practices Tirzepatide (Mounjaro®) Weight Loss Clinic

WTW is tracking over 40 weight loss vendor programs marketing to employers

If you believe the medication is causing intolerable mood symptoms, work with your provider to develop an appropriate plan

Future research should prioritize the development of next-generation agonists, explore combination therapies, and integrate precision medicine approaches to optimize patient outcomes

At day 85 (approximately 12 weeks), patients in the low-dose group lost an average of 7.19 percent of their body weight and the high-dose group lost an average of 14.52 percent of their body weight, while the placebo group gained an average of 1.49 percent of their body weight